Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Verena K. Preisler"'
Autor:
Jochen Willner, Jan Helms, Klaus Bratengeier, Rudolf Hagen, Michael Flentje, Leo Pfreundner, Verena K. Preisler, Florian Hoppe
Publikováno v:
Radiotherapy and Oncology. 68:163-170
Background : To evaluate the effect of paclitaxel/cisplatin induction chemotherapy (ICHT) and CT-based radiotherapy (RT) on larynx preservation, tumor control, and survival in patients with larynx/hypopharynx carcinoma eligible for total laryngectomy
Publikováno v:
Mutagenesis. 15:91-97
Aflatoxin B1 is a human hepatocarcinogen. It is also a known point mutagen in bacteria and mammalian cells. This mutagenic activity may be at least partly responsible for its carcinogenic activity. However, recent studies show that aflatoxin B1 induc
Publikováno v:
Laryngo-Rhino-Otologie. 77:207-212
Background Secondary lymphedema of the head and neck can develop as a result of obstruction of lymphatic channels following the surgical removal of lymph nodes and fibrosis due to irradiation. This can be treated with manual lymphatic drainage. An in
Autor:
Verena K. Preisler, Detlev Schindler, Helga Stopper, Florian Hoppe, Rudolf Hagen, Leo Pfreundner, Richard Friedl
Publikováno v:
Acta Oto-Laryngologica. 118:600-605
Paclitaxel (Taxol) is an antimicrotubular agent which blocks the cells in the G2/M phase of the cell cycle. Because of this mechanism it is presumed that this drug could function as a radiation sensitizer. The cytotoxic and genotoxic effects of pacli
Publikováno v:
Cancer letters. 145(1-2)
Paclitaxel is an antimicrotubular agent that blocks the cells in the G2/M phase of the cell cycle. Due to this action, it is presumed that this drug could function as a radiation sensitizer. We studied the genotoxic effects of a combination of paclit